Synonyms EBV-Related Lymphoproliferative Disorder, EBV-associated lymphoproliferative disorder, Epstein-Barr Virus-Associated Lymphoproliferative Disorder + [5] |
Introduction A lymphoproliferative disorder associated with Epstein-Barr virus. This category includes, but is not limited to, Burkitt lymphoma, classic Hodgkin lymphoma, and lymphomas arising in immunocompromised individuals. |
Target |
Mechanism CD19 modulators |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism HDAC1 inhibitors [+2] |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date31 Oct 2022 |
Sponsor / Collaborator |
Start Date01 Oct 2022 |
Sponsor / Collaborator |
Start Date01 Feb 2022 |
Sponsor / Collaborator |